PHAT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Phathom Pharmaceuticals (PHAT) Earnings Date & Reports

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PHAT is expected to report earnings to rise 46.84% to -115 cents per share on May 13

Phathom Pharmaceuticals PHAT Stock Earnings Reports

Q1'25

Est.

$-1.16

Q4'24

Beat

by $0.42

Q3'24

Beat

by $0.15

Q2'24

Missed

by $0.24

Q1'24

Beat

by $0.09

The last earnings report on March 06 showed earnings per share of -79 cents, beating the estimate of -121 cents. With 1.24M shares outstanding, the current market capitalization sits at 306.40M.

View a ticker or compare two or three

Compare

PHAT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PHAT
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for PHAT (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

100 Campus Drive

Phone

+1 877 742-8466

Employees

452

Web

https://www.phathompharma.com